INTRODUCTION {#s1}
============

Current studies have well documented that the interaction between various environmental factors and certain genetic polymorphisms may lead to CAD \[[@R1]\]. Many association studies between polymorphisms of matrix metalloproteases (MMPs) gene and CAD have been carried out \[[@R2], [@R3]\]. These studies showed that MMPs is associated with a higher risk of plaque rupture/atherosclerosis and adverse cardiovascular events in patients undergoing CAD \[[@R4]\].

Matrix metallopeptidases 9 (MMP9) has been focused on the value of degrade a wide range of extracellular matrix proteins in patients \[[@R5]\]. MMP 9 is regulated primarily at the transcription level and posttranslational by activation of the zymogen and by inhibition of the endogenous inhibitor TIMP-1\[[@R6]\]. Although various studies between MMP9 and CAD have been reported, the conclusions are not consistent. The MMP9 C-1562T (rs3918242) in the promoter region is of special interest, which was considered a close association with CAD by many studies. Up to now, lots of case-control studies and systematic reviews on the relation between rs3918242 and CAD were carried out. However, the conclusions were inconsistent. Based on these observations, to investigate a more accurate estimation of the relationship between CAD and rs3918242, we conducted an update meta-analysis.

RESULTS {#s2}
=======

Study characteristics {#s2_1}
---------------------

A total of 37 studies \[[@R7]--[@R41]\] including 13,035 cases and 11,372 controls were identified in this meta-analysis. The Figure [1](#F1){ref-type="fig"} show that the study selection process. [Supplementary Table 1](#SD1){ref-type="supplementary-material"} and Table [1](#T1){ref-type="table"} have summarized the main characteristics of included studies. In all studies, the genotype frequencies in controls were in consistent with HWE. The results of NOS showed that the methodological quality of be included studies were mostly good (6--9 stars).

![Flow chart of meta-analysis for exclusion /inclusion of individual studies](oncotarget-09-9468-g001){#F1}

###### Characteristics of included studies

  Reference           Year   Ethnicity   Case   Control                                                           
  ------------------- ------ ----------- ------ --------- ----- ---- ------ ----- ------ ------ ----- ---- ------ -----
  Wang et al.         2001   Caucasian   619    479       128   12   1086   152   169    128    41    0    297    41
  Pollanen et al.     2001   Caucasian   109    78        21    10   177    41    167    124    30    13   278    56
  Cho et al.          2002   Asian       63     48        15    0    111    15    67     63     4     0    130    4
  Kim et al.          2002   Asian       131    99        32    0    230    32    117    85     32    0    202    32
  Morgan et al.       2003   Caucasian   998    779       203   16   1761   235   265    223    42    0    488    42
  Haberbosch et al.   2005   Caucasian   2098   1596      469   33   3661   535   633    485    132   16   1102   164
  Chen et al.         2005   Asian       78     57        21    0    135    21    81     73     8     0    154    8
  Tang et al.         2005   Asian       101    73        27    1    173    29    105    91     13    1    195    15
  Meng et al.         2006   Asian       117    91        26    0    208    26    99     80     18    1    178    20
  Nuzzo et al.        2006   Caucasian   115    73        39    3    185    45    123    86     36    1    208    38
  Horne et al.        2007   Caucasian   1693   1219      440   34   2878   508   3455   2591   795   69   5977   933
  Nanni et al.        2007   Caucasian   200    136       62    2    334    66    201    135    63    3    333    69
  Chen et al.         2007   Asian       150    97        48    5    242    58    70     61     6     3    128    12
  Chen et al.         2007   Asian       110    92        13    5    197    23    70     61     6     3    128    12
  Wang et al.         2007   Asian       64     46        17    1    109    19    84     66     18    0    150    18
  Koh et al.          2008   Asian       206    151       52    3    354    58    173    142    31    0    315    31
  Zhang et al.        2008   Asian       92     67        22    3    156    28    95     83     12    0    178    12
  Alp et al.          2009   Caucasian   146    99        42    5    240    52    122    90     29    3    209    35
  Wu et al.           2009   Asian       791    628       155   8    1411   171   689    545    143   1    1233   145
  Wu et al.           2009   Asian       370    289       77    4    655    85    689    545    143   1    1233   145
  Fallah et al.       2010   Asian       145    77        57    11   211    79    157    62     76    19   200    114
  Zhi et al.          2010   Asian       762    585       174   3    1344   180   555    442    110   3    994    116
  Gao et al.          2010   Asian       96     49        38    9    136    56    78     59     18    1    136    20
  Ma et al.           2010   Asian       347    251       83    13   585    109   403    346    53    4    745    61
  Yong et al.         2010   Asian       128    97        30    1    224    32    106    92     14    0    198    14
  Ghaderian et al.    2011   Asian       234    177       47    10   401    67    200    141    53    6    335    65
  Wang et al.         2011   Asian       352    261       80    11   602    102   421    355    61    5    771    71
  Opstad et al.       2012   Caucasian   996    756       225   15   1737   255   204    154    46    4    354    54
  Wang et al.         2012   Asian       384    286       87    11   659    109   451    373    72    6    818    84
  Spurthi et al.      2012   Asian       100    40        47    13   127    73    100    48     46    6    142    58
  Han et al.          2012   Asian       91     65        25    1    155    27    101    75     25    1    175    27
  Sewelam et al.      2013   Caucasian   40     32        7     1    71     9     40     40     0     0    80     0
  Yang et al.         2013   Asian       240    186       47    7    419    61    200    161    35    4    357    43
  Wu et al.           2013   Asian       258    193       56    9    442    74    153    131    22    0    284    22
  Xu et al.           2013   Asian       382    268       109   5    645    119   466    361    103   2    825    107
  Lu et al.           2014   Asian       168    102       62    4    266    70    208    156    50    2    362    54
  Yuan et al.         2014   Asian       61     48        11    2    107    15    55     38     16    1    92     18

Meta-analysis {#s2_2}
-------------

Table [2](#T2){ref-type="table"} presents a principal results of this studies. For the rs3918242 polymorphism, heterogeneity was found in the allelic (I^2^ = 66%, *p* \< 0.00001) and dominant (I^2^ = 65%, *p* \< 0.00001) models, but not in the recessive model (I^2^ = 22%, *p* = 0.13). Therefore, We performed a random-effects and fixed-effects method to merge the ORs. The meta-analysis results showed that significant statistical association between rs3918242 polymorphism and the risk of CAD in allelic (OR 1.34; 95% CI 1.20--1.55; *p* \< 0.00001), recessive (OR 1.43; 95% CI 1.17--1.75; *p* = 0.0004) and dominant (OR 1.36; 95% CI 1.20--1.53; *p* \< 0.00001) models.

###### Results From a meta-analysis of the association between CAD and matrix metalloproteinase 9 C-1562T polymorphism

  Polymorphism and Subgroup   No. of Studies       No. of Cases   No. of Controls   Genotype                                                                                                                                    
  --------------------------- -------------------- -------------- ----------------- ------------------- ------------------- ------------------- ------------------- ------------------- ------------------- ------------------- ------
  **Ethnicity**               **All population**   37             13035             11372               1.34 (1.20, 1.50)   \< 0.00001          1.43 (1.17, 1.75)   0.0004              1.36 (1.20, 1.53)   \< 0.00001          
  **Caucasian**               10                   7014           5379              1.11 (0.99, 1.25)   0.07                1.06 (0.80, 1.40)   0.70                1.13 (1.01, 1.26)   0.03                                    
  **Asian**                   27                   6021           5993              1.45 (1.25, 1.69)   \< 0.00001          1.94 (1.45, 2.58)   \< 0.00001          1.48 (1.25, 1.75)   \< 0.00001                              
  **Outcome**                 **Caucasian**        CAD            6                 4966                1560                1.08 (0.96, 1.23)   0.20                1.07 (0.71, 1.61)   0.75                1.09 (0.95, 1.26)   0.20
  MI                          4                    2048           3819              1.14 (1.02, 1.27)   0.02                1.05 (0.71, 1.55)   0.81                1.17 (1.04, 1.32)   0.01                                    
  **Asian**                   CAD                  18             3799              3400                1.35 (1.12, 1.62)   0.002               1.73 (1.20, 2.51)   0.004               1.35 (1.11, 1.65)   0.003               
  MI                          9                    2222           2593              1.66 (1.29, 2.14)   \< 0.0001           2.29 (1.44, 3.63)   0.004               1.74 (1.29, 2.35)   0.0003                                  

In addition, a subgroup analysis was conducted according to ethnics. In Caucasians, no significant statistical association between rs3918242 polymorphism and CAD either in allelic (OR 1.11; 95% CI 0.99--1.25; *p* = 0.07) or recessive (OR 1.06; 95% CI 0.80--1.40; *p* = 0.70) models. But significant statistical association was observed in dominant (OR1.13; 95% CI 1.01--1.26; *p* = 0.03) model. In Asians, significant statistical association was found between rs3918242 and CAD in allelic contrast (OR 1.45; 95% CI 1.25--1.69; *p* \< 0.00001), recessive(OR 1.94; 95% CI 1.45--2.58; *p* \< 0.00001) and dominant (OR 1.48; 95% CI 1.25--1.75; *p* \< 0.00001) models (Figures [2](#F2){ref-type="fig"}--[7](#F7){ref-type="fig"}).

![Forest plot of the meta-analysis of the association between MMP-9 C-1562T(rs3918242) and CAD or MI risks in an allele genetic model in Caucasians subgroup](oncotarget-09-9468-g002){#F2}

![Forest plot of the meta-analysis of the association between MMP-9 C-1562T(rs3918242) and CAD or MI risks in a recessive genetic model in Caucasians subgroup](oncotarget-09-9468-g003){#F3}

![Forest plot of the meta-analysis of the association between MMP-9 C-1562T(rs3918242) and CAD or MI risks in a dominant genetic model in Caucasians subgroup](oncotarget-09-9468-g004){#F4}

![Forest plot of the meta-analysis of the association between MMP-9 C-1562T(rs3918242) and CAD or MI risks in an allele genetic model in Asians subgroup](oncotarget-09-9468-g005){#F5}

![Forest plot of the meta-analysis of the association between MMP-9 C-1562T(rs3918242) and CAD or MI risks in a recessive genetic model in Asians subgroup](oncotarget-09-9468-g006){#F6}

![Forest plot of the meta-analysis of the association between MMP-9 C-1562T(rs3918242) and CAD or MI risks in a dominant genetic model in Asians subgroup](oncotarget-09-9468-g007){#F7}

Sensitivity analyses {#s2_3}
--------------------

We excluded individual studies one at a time and recalculated the pooled *p* or OR for the remaining studies. The results proved that the ORs were not changed obviously, which suggested that this results are stable.

Publication bias {#s2_4}
----------------

Egger's test and Funnel plot were conducted to evaluate the publication bias of all contrast models. No obvious bias was found in our study. No obvious asymmetry was found in the funnel plot for the allelic, recessive and dominant genetic models (Figure [8](#F8){ref-type="fig"}). Further, Egger's test be used to detect the whole publication bias. No statistically significant of publication bias was detected in allelic (*p* = 0.592), recessive (*p* = 0.103) and dominant (*p* = 0.683) models. The same was true in the subgroup analysis.

![Funnel plot of the association between MMP-9 C-1562T(rs3918242) and CAD risk in all populations\
(**A**) The allele genetic model in all populations. (**B**) The recessive genetic model in all populations. (**C**) The dominant genetic model in all populations.](oncotarget-09-9468-g008){#F8}

DISCUSSION {#s3}
==========

Our meta-analysis showed that rs3918242 polymorphism was linked with an increased risk of CAD in Asians. More available evidence supports the fact that the rs3918242 as a risk factor association with MI both in Asian and Caucasian populations. MMP-9 might be particularly important in matrix degradation and the subsequent atherosclerotic plaque rupture because of its extensive substrate specificity and distal position in the proteolytic cascade reaction \[[@R42]\]. Loftus et al. reported that MMP-9 concentration and activity were significantly higher in unstable atherosclerotic plaque with intense inflammatory cell infiltration, hence contributing to the plaque rupture ultimately \[[@R43]\]. Opstad et al. suggested that patients with previous MI were associated with the higher MMP-9 gene expression \[[@R32]\]. The current study data from animal experiment, observation of circulating markers and expression investigations on atherosclerotic tissue, has indicated a role of MMP-9 in atherosclerosis. However, the association of rs3918242 polymorphism with CAD and MI risks remains inclusive, although several meta-analysis research (Wang et al. \[[@R42]\], Abilleira et al. \[[@R44]\], Juan et al. \[[@R45]\]) have been published. Wang \[[@R42]\] performed a meta-analysis which included sixteen case-control studies to evaluate the association between rs3918242 and CAD. Subgroup analysis was performed according to different races and outcome(CAD or MI). The final conclusion suggested that an obvious ethnic difference. MMP-9 C1562T polymorphism was associated with CAD or MI in East Asians. But not to west Asians or western populations. Abilleira \[[@R43]\] presented a study of available data from five studies and did not find association of MMP9 polymorphism with CAD. Also, they did not have further specific analysis and subgroup analysis. Juan \[[@R44]\] collected all publications on the association between rs3918242 polymorphism and MI which included 7 researchs. Their data showed that the rs3918242 is a risk factor for white populations, but not for Asian populations.

In order to obtain reliable conclusion, we implemented an update meta-analysis involving 37 studies to provide the relationship between rs3918242 and CAD or MI risks. The study revealed that rs3918242 possibly increased the risk of MI in both Asian and Caucasian populations. As compared with the former studies \[[@R43]--[@R45]\], our findings has a lot of novelty. Firstly, although lots of studies and systematic review have reported this association, the conclusions were inconsistent or inconclusive. Therefore, our research is urgent and meaningful. Secondly, our meta-analysis is superior to the others, due to the far larger number of participants (37 included studies with 13,035 cases and 11,372 controls) which were from all over the world. The substantially large sample size ensures the reliability of the results. Thirdly, subgroup analysis was further conducted according to different races.

There are several possible metabolic and molecular mechanisms to explain our conclusion. Zhang \[[@R46]\] have suggested that the C-1562T polymorphic locus is important for the regulatory element that the mutation appeared to be a binding site for a transcription repressor protein and T-allelic promoter had a higher promoter activity. Moreover, more evidences have indicated that the MMP-9 have associated with cell migration and proliferation \[[@R47]\]. More important, the overexpression and activity of MMP-9(rs3918242) was monitored in unstable atherosclerotic plaques \[[@R48]\]. These evidences were in line with our results.

Several limitations should to be pointed out. Risk of bias and unobservable heterogeneity may disturb the results. Included studies of language limit to English and Chinese, missing some studies by other languages. Some hardly to be avoided publication bias might exist. Such as some factors like age, gender, individual conditions, environment and experimental method are different, those might influence the interpretation of result in our meta-analysis.

In conclusion, the meta-analysis provided evidence that MMP9 rs3918242 polymorphism was significantly associated with CAD/ MI in Asian populations. The same of available evidence supports the fact that the rs3918242 is a risk factor for MI in Caucasian populations. Larger studies with the consideration of more influence factors and better study designs are still required to further evaluate the connection of MMP9 rs3918242 polymorphism with CAD/MI susceptibility.

MATERIALS AND METHODS {#s4}
=====================

Literature search {#s4_1}
-----------------

All studies that researched the association between the rs3918242 polymorphism and CAD were identified by comprehensive computer-based searches of PubMed, Web of Science, the Cochrane Library, Wanfang Data and China National Knowledge Infrastructure (CNKI). The language was limited to English and Chinese articles before Feb.2016. The following keywords were used : \#1 matrix metalloproteinase \[MeSH\]; \#2 matrix metalloproteinase 9 \[MeSH\]; \#3 polymorphism \[MeSH\]; \#4 mutation \[MeSH\]; \#5 variation \[MeSH\]; \#6 genotype \[MeSH\]; \#7 coronary artery disease \[MeSH\]; \#8 coronary heart disease \[MeSH\]; \#9 myocardial Infarction \[MeSH\]; \#10 ischemic cardiovascular disease\[MeSH\]. The retrieval strategy is \#1 or \#2 and \#3 or \#4 or \#5 or \#6 and \#7 or \#8 or \#9 or \#10.

Inclusion criteria {#s4_2}
------------------

The diagnosis of CAD was fitted to the examination results of coronary arteriography, treadmill exercise test, clinical symptoms combined with electrocardiogram, as well as some other inspection project, for example echocardiography and myocardial perfusion imaging. The inclusion criteria for eligible studies were as follows: (1) independent case-control studies using either a hospital-based or a population-based design; (2) the studies of MMP9 C-1562T polymorphism and CAD risk; (3) the studies has an intact original data on genotype distribution and a comprehensive statistical index, sufficient data for estimating an odds ratio (OR) with 95% confidence interval (CI); (4) no repeat published data.

Exclusion criteria {#s4_3}
------------------

We excluded studies if (1) reviews, editorials, and articles with insufficient information; (2) the genotype distribution in the control group non-conformity the Hardy-Weinberg equilibrium.

Data extraction {#s4_4}
---------------

Two authors independently extracted the data. The extracted information included the first author's name, publication year, study population, number of genotypes, genotyping methods, allele frequency of cases and controls, sample sizes in the cases and controls, sex and age of cases and controls. Disagreement was resolved by consensus. If these two authors could not reach a consensus, the result was reviewed by a third author.

Quality assessment {#s4_5}
------------------

To determine the methodological quality of the included studies, we used the Newcastle--Ottawa scale \[[@R49]\], which uses a "star" rating system to judge the quality of observational studies. The NOS ranges between zero (worst) up to nine stars (best). Two authors assessed the quality of included studies independently and solved disagreement through discussion.

Statistical analysis {#s4_6}
--------------------

The association between rs3918242 polymorphism and CAD, which in our meta-analysis were compared by using the OR and its corresponding to 95% CI. Hardy--Weinberg equilibrium (HWE) was assessed by Chi-square test in control groups, and *P* \< 0.05 was considered a significant departure from HWE. Heterogeneity between studies was assessed by I^2^ test, *p* \< 0.10 and I^2^ \> 50% indicated evidence of heterogeneity. If heterogeneity existed among the studies, the random effects model was used to estimate the pooled OR (the DerSimonian and Kacker method). Otherwise, the fixed effects model was adopted (the Mantel--Haenszel method) \[[@R50], [@R51]\]. The associations between the genetic variant and CAD risk of pooled ORs were performed for a recessive genetic model, dominant genetic model and allelic contrast. Z test was used to determine the pooled OR and significance was set at *p* \< 0.05. Besides, subgroup analyses were stratified by ethnicity and outcome. The potential publication bias was checked by using funnel plots and Egger's test \[[@R52]\]. The statistical analysis was performed by using Review Manager 5.30 (Cochrane Collaboration, The Nordic Cochrane Centre, Copenhagen) and Stata 12.0 software (StataCorp, College Station, TX, USA). A two-tailed *p* \< 0.05 was considered significant.

SUPPLEMENTARY MATERIALS AND TABLE {#s5}
=================================
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